<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">systhiper</journal-id><journal-title-group><journal-title xml:lang="ru">Системные гипертензии</journal-title><trans-title-group xml:lang="en"><trans-title>Systemic Hypertension</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2075-082X</issn><issn pub-type="epub">2542-2189</issn><publisher><publisher-name>LLC «ИнтерМедсервис»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">systhiper-739</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ARTICLES</subject></subj-group></article-categories><title-group><article-title>Фиксированная комбинация b-блокатора и диуретика у пациентов с артериальной гипертонией высокого риска</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чазова</surname><given-names>И. Е.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ратова</surname><given-names>Л. Г.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ФГБУ Российский кардиологический научно-производственный комплекс Минздрава РФ</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>09</day><month>02</month><year>2023</year></pub-date><volume>9</volume><issue>2</issue><fpage>10</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чазова И.Е., Ратова Л.Г., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Чазова И.Е., Ратова Л.Г.</copyright-holder><copyright-holder xml:lang="en">Чазова И.Е., Ратова Л.Г.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.syst-hypertension.ru/jour/article/view/739">https://www.syst-hypertension.ru/jour/article/view/739</self-uri></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Papademetriou V, Prisant LM, Weber M et al. Low-dose combination therapy in the management of hypertension. Primary Cardiol 1995; 21: 29-31.</mixed-citation><mixed-citation xml:lang="en">Papademetriou V, Prisant LM, Weber M et al. Low-dose combination therapy in the management of hypertension. Primary Cardiol 1995; 21: 29-31.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Диагностика и лечение артериальной гипертензии. Российские рекомендации (4-й пересмотр). Системные гипертензии. 2010; 3: 3-25.</mixed-citation><mixed-citation xml:lang="en">Диагностика и лечение артериальной гипертензии. Российские рекомендации (4-й пересмотр). Системные гипертензии. 2010; 3: 3-25.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">James IM. Which antihypertensive? Br J Clin Pract 1990; 44: 102-5.</mixed-citation><mixed-citation xml:lang="en">James IM. Which antihypertensive? Br J Clin Pract 1990; 44: 102-5.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Enlund H, Turakka H, Tuomilehto J. Combination therapy in hypertension: a population-based study in eastern Finland. Eur J Clin Pharmacol 1981; 21: 1-8.</mixed-citation><mixed-citation xml:lang="en">Enlund H, Turakka H, Tuomilehto J. Combination therapy in hypertension: a population-based study in eastern Finland. Eur J Clin Pharmacol 1981; 21: 1-8.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Brunner HR, Menhard J, Waeber B et al. Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations. J Hypertens 1990; 8: 3-11.</mixed-citation><mixed-citation xml:lang="en">Brunner HR, Menhard J, Waeber B et al. Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations. J Hypertens 1990; 8: 3-11.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Epstein M, Bakris G. Newer approaches to antihypertensive therapy: use of fixed-dose combination therapy. Arch Intern Med 1996; 156: 1969-78.</mixed-citation><mixed-citation xml:lang="en">Epstein M, Bakris G. Newer approaches to antihypertensive therapy: use of fixed-dose combination therapy. Arch Intern Med 1996; 156: 1969-78.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Alderman MH. Which antihypertensive drugs first - and why! JAMA 1992; 267: 2786-7.</mixed-citation><mixed-citation xml:lang="en">Alderman MH. Which antihypertensive drugs first - and why! JAMA 1992; 267: 2786-7.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Collins R, Peto R, MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38.</mixed-citation><mixed-citation xml:lang="en">Collins R, Peto R, MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405-12.</mixed-citation><mixed-citation xml:lang="en">MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405-12.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bakris GL, Frohlich ED. The evolution of antihypertensive therapy: an overview of four decades of experience. J Am Coll Cardiol 1989; 14: 1595-608.</mixed-citation><mixed-citation xml:lang="en">Bakris GL, Frohlich ED. The evolution of antihypertensive therapy: an overview of four decades of experience. J Am Coll Cardiol 1989; 14: 1595-608.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Prisant LM, Neutel JM, Papademetriou V et al. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies. Am J Ther 1998; 5: 313-21.</mixed-citation><mixed-citation xml:lang="en">Prisant LM, Neutel JM, Papademetriou V et al. Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies. Am J Ther 1998; 5: 313-21.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Ратова Л.Г. Фиксированная комбинация b-блокатора и диуретика в лечении больных артериальной гипертонией. Системные гипертензии. 2010; 4: 25-8.</mixed-citation><mixed-citation xml:lang="en">Чазова И.Е., Ратова Л.Г. Фиксированная комбинация b-блокатора и диуретика в лечении больных артериальной гипертонией. Системные гипертензии. 2010; 4: 25-8.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dequattro V, Weir MR. Bisoprolol fumarate. Hydrochlorothiazide 6.25 mg: a new low-dose option for first-line antihypertensive therapy. Adv Ther 1993; 10: 197-206.</mixed-citation><mixed-citation xml:lang="en">Dequattro V, Weir MR. Bisoprolol fumarate. Hydrochlorothiazide 6.25 mg: a new low-dose option for first-line antihypertensive therapy. Adv Ther 1993; 10: 197-206.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Frishman WH, Bryzinski BS, Coulson LR et al. A multifactorial trial design to assess combination therapy in hypertension: treatment with Bisoprolol and Hydrochlorothiazide. Arch Intern Med 1994; 154: 1461-8.</mixed-citation><mixed-citation xml:lang="en">Frishman WH, Bryzinski BS, Coulson LR et al. A multifactorial trial design to assess combination therapy in hypertension: treatment with Bisoprolol and Hydrochlorothiazide. Arch Intern Med 1994; 154: 1461-8.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Frishman WH, Burris JF, Mroczek WJ et al. First-line therapy option with low-dose Bisoprolol fumarate and low-dose Hydrochlo-rothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol 1995; 35: 182-8.</mixed-citation><mixed-citation xml:lang="en">Frishman WH, Burris JF, Mroczek WJ et al. First-line therapy option with low-dose Bisoprolol fumarate and low-dose Hydrochlo-rothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol 1995; 35: 182-8.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Neutel JM, Rolf CN, Valentine SN et al. Low-dose combination therapy as first line treatment of mild to moderate hypertension: the efficacy and safety of Bisoprolol/6.25 HCTZ versus Amlodipine, Enalapril, and placebo. Car-diovasc Rev Rep 1996; 17: 33-45.</mixed-citation><mixed-citation xml:lang="en">Neutel JM, Rolf CN, Valentine SN et al. Low-dose combination therapy as first line treatment of mild to moderate hypertension: the efficacy and safety of Bisoprolol/6.25 HCTZ versus Amlodipine, Enalapril, and placebo. Car-diovasc Rev Rep 1996; 17: 33-45.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Prisant LM, Weir MR, Papademetriou V et al. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J 1995; 130: 359-66.</mixed-citation><mixed-citation xml:lang="en">Prisant LM, Weir MR, Papademetriou V et al. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J 1995; 130: 359-66.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Benetos A, Consoli S, Safavian A et al. Efficacy, safety, and effects on quality of life of Bisoprolol. Hydrochlorothiazide versus Amlodipine in elderly patients with systolic hypertension. Am Heart J 2000; 140: e14.</mixed-citation><mixed-citation xml:lang="en">Benetos A, Consoli S, Safavian A et al. Efficacy, safety, and effects on quality of life of Bisoprolol. Hydrochlorothiazide versus Amlodipine in elderly patients with systolic hypertension. Am Heart J 2000; 140: e14.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
